Annual report
7376.TEDINET S100SHQS
Period2022-10-01 → 2023-09-30
Filed2023-12-22
StandardJapan GAAP
ConsolidatedNo
Data checks13 of 13 passed
Key figures · 86
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥1.3bn | 2022-10-01 → 2023-09-30 | Standalone | Net sales |
| Revenue | ¥1.1bn | 2021-10-01 → 2022-09-30 | Standalone | Net sales |
| Revenue | ¥1.1bn | 2020-10-01 → 2021-09-30d | Standalone | Net sales (5-year summary) |
| Revenue | ¥1.0bn | 2019-10-01 → 2020-09-30d | Standalone | Net sales (5-year summary) |
| Revenue | ¥1.0bn | 2018-10-01 → 2019-09-30d | Standalone | Net sales (5-year summary) |
| Operating income | ¥67m | 2022-10-01 → 2023-09-30 | Standalone | Operating income |
| Operating income | ¥48m | 2021-10-01 → 2022-09-30 | Standalone | Operating income |
| Ordinary income | ¥66m | 2022-10-01 → 2023-09-30 | Standalone | Ordinary income |
| Ordinary income | ¥51m | 2021-10-01 → 2022-09-30 | Standalone | Ordinary income |
| Ordinary income | ¥113m | 2020-10-01 → 2021-09-30d | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | ¥45m | 2019-10-01 → 2020-09-30d | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | ¥42m | 2018-10-01 → 2019-09-30d | Standalone | Ordinary income loss (5-year summary) |
| Profit before tax | ¥61m | 2022-10-01 → 2023-09-30 | Standalone | Income before income taxes |
| Profit before tax | ¥45m | 2021-10-01 → 2022-09-30 | Standalone | Income before income taxes |
| Net income | ¥45m | 2022-10-01 → 2023-09-30 | Standalone | Profit loss |
| Net income | ¥32m | 2021-10-01 → 2022-09-30 | Standalone | Profit loss |
| Net income | ¥76m | 2020-10-01 → 2021-09-30d | Standalone | Net income loss (5-year summary) |
| Net income | ¥31m | 2019-10-01 → 2020-09-30d | Standalone | Net income loss (5-year summary) |
| Net income | ¥51m | 2018-10-01 → 2019-09-30d | Standalone | Net income loss (5-year summary) |
| Total assets | ¥915m | at 2023-09-30 | Standalone | Assets |
| Total assets | ¥830m | at 2022-09-30 | Standalone | Assets |
| Total assets | ¥813m | at 2021-09-30d | Standalone | Total assets (5-year summary) |
| Total assets | ¥467m | at 2020-09-30d | Standalone | Total assets (5-year summary) |
| Total assets | ¥462m | at 2019-09-30d | Standalone | Total assets (5-year summary) |
| Total liabilities | ¥268m | at 2023-09-30 | Standalone | Liabilities |
| Total liabilities | ¥217m | at 2022-09-30 | Standalone | Liabilities |
| Net assets / equity | ¥647m | at 2023-09-30 | Standalone | Net assets |
| Net assets / equity | ¥613m | at 2022-09-30 | Standalone | Net assets |
| Net assets / equity | ¥575m | at 2021-09-30d | Standalone | Net assets |
| Net assets / equity | ¥210m | at 2020-09-30d | Standalone | Net assets (5-year summary) |
| Net assets / equity | ¥179m | at 2019-09-30d | Standalone | Net assets (5-year summary) |
| Cash and deposits | ¥643m | at 2023-09-30 | Standalone | Cash and deposits |
| Cash and deposits | ¥597m | at 2022-09-30 | Standalone | Cash and deposits |
| Cash & equivalents | ¥643m | at 2023-09-30 | Standalone | Cash and cash equivalents |
| Cash & equivalents | ¥597m | at 2022-09-30 | Standalone | Cash and cash equivalents |
| Cash & equivalents | ¥615m | at 2021-09-30d | Standalone | Cash and cash equivalents |
| Cash & equivalents | ¥264m | at 2020-09-30d | Standalone | Cash and cash equivalents (5-year summary) |
| Cash & equivalents | ¥247m | at 2019-09-30d | Standalone | Cash and cash equivalents (5-year summary) |
| Operating cash flow | ¥88m | 2022-10-01 → 2023-09-30 | Standalone | Net cash provided by used in operating activities |
| Operating cash flow | −¥627,000 | 2021-10-01 → 2022-09-30 | Standalone | Net cash provided by used in operating activities |
| Operating cash flow | ¥135m | 2020-10-01 → 2021-09-30d | Standalone | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥62m | 2019-10-01 → 2020-09-30d | Standalone | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥68m | 2018-10-01 → 2019-09-30d | Standalone | Net cash provided by used in operating activities (5-year summary) |
| Investing cash flow | −¥45m | 2022-10-01 → 2023-09-30 | Standalone | Net cash provided by used in investment activities |
| Investing cash flow | −¥24m | 2021-10-01 → 2022-09-30 | Standalone | Net cash provided by used in investment activities |
| Investing cash flow | −¥2m | 2020-10-01 → 2021-09-30d | Standalone | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥10m | 2019-10-01 → 2020-09-30d | Standalone | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | ¥13m | 2018-10-01 → 2019-09-30d | Standalone | Net cash provided by used in investing activities (5-year summary) |
| Financing cash flow | ¥3m | 2022-10-01 → 2023-09-30 | Standalone | Net cash provided by used in financing activities |
| Financing cash flow | ¥6m | 2021-10-01 → 2022-09-30 | Standalone | Net cash provided by used in financing activities |
| Financing cash flow | ¥217m | 2020-10-01 → 2021-09-30d | Standalone | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | −¥35m | 2019-10-01 → 2020-09-30d | Standalone | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | −¥46m | 2018-10-01 → 2019-09-30d | Standalone | Net cash provided by used in financing activities (5-year summary) |
| EPS (basic) | ¥40.85 | 2022-10-01 → 2023-09-30 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥29.11 | 2021-10-01 → 2022-09-30 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥82.99 | 2020-10-01 → 2021-09-30d | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥35.76 | 2019-10-01 → 2020-09-30d | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥59.71 | 2018-10-01 → 2019-09-30d | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (diluted) | ¥39.64 | 2022-10-01 → 2023-09-30 | Standalone | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥28.45 | 2021-10-01 → 2022-09-30 | Standalone | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥78.75 | 2020-10-01 → 2021-09-30d | Standalone | Diluted earnings per share (5-year summary) |
| Net assets per share | ¥582.38 | at 2023-09-30 | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥550.42 | at 2022-09-30 | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥520.37 | at 2021-09-30d | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥243.48 | at 2020-09-30d | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥207.72 | at 2019-09-30d | Standalone | Net assets per share (5-year summary) |
| Equity ratio | 70.7% | at 2023-09-30 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 73.8% | at 2022-09-30 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 70.7% | at 2021-09-30d | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 44.9% | at 2020-09-30d | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 38.7% | at 2019-09-30d | Standalone | Equity to asset ratio (5-year summary) |
| ROE | 7.2% | 2022-10-01 → 2023-09-30 | Standalone | Rate of return on equity (5-year summary) |
| ROE | 5.4% | 2021-10-01 → 2022-09-30 | Standalone | Rate of return on equity (5-year summary) |
| ROE | 19.4% | 2020-10-01 → 2021-09-30d | Standalone | Rate of return on equity (5-year summary) |
| ROE | 15.9% | 2019-10-01 → 2020-09-30d | Standalone | Rate of return on equity (5-year summary) |
| ROE | 33.6% | 2018-10-01 → 2019-09-30d | Standalone | Rate of return on equity (5-year summary) |
| Shares issued | 1,119,740 | at 2023-09-30 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 1,113,800 | at 2022-09-30 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 1,105,520 | at 2021-09-30d | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 14,350 | at 2020-09-30d | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 14,350 | at 2019-09-30d | Standalone | Total number of issued shares (5-year summary) |
| Employees | 200 | at 2023-09-30 | Standalone | Number of employees |
| Employees | 191 | at 2022-09-30 | Standalone | Number of employees |
| Employees | 173 | at 2021-09-30d | Standalone | Number of employees |
| Employees | 162 | at 2020-09-30d | Standalone | Number of employees |
| Employees | 154 | at 2019-09-30d | Standalone | Number of employees |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 63
| Segment | Item | Period | Value |
|---|---|---|---|
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue | 2022-10-01 → 2023-09-30 | ¥4m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue external | 2022-10-01 → 2023-09-30 | ¥4m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment profit | 2022-10-01 → 2023-09-30 | −¥12m |
| Reconciling Itemsreconciling | capex | 2022-10-01 → 2023-09-30 | ¥25m |
| Reconciling Itemsreconciling | depreciation | 2022-10-01 → 2023-09-30 | ¥1m |
| Reconciling Itemsreconciling | segment assets | at 2023-09-30 | ¥750m |
| Reconciling Itemsreconciling | segment profit | 2022-10-01 → 2023-09-30 | −¥184m |
| Health Care Businessreportable segment | capex | 2022-10-01 → 2023-09-30 | ¥189,000 |
| Health Care Businessreportable segment | depreciation | 2022-10-01 → 2023-09-30 | ¥235,000 |
| Health Care Businessreportable segment | employees | at 2023-09-30 | 14 pure |
| Health Care Businessreportable segment | revenue | 2022-10-01 → 2023-09-30 | ¥156m |
| Health Care Businessreportable segment | revenue external | 2022-10-01 → 2023-09-30 | ¥156m |
| Health Care Businessreportable segment | segment assets | at 2023-09-30 | ¥25m |
| Health Care Businessreportable segment | segment profit | 2022-10-01 → 2023-09-30 | ¥457,000 |
| IT Sales Outsourcing Businessreportable segment | capex | 2022-10-01 → 2023-09-30 | ¥5m |
| IT Sales Outsourcing Businessreportable segment | depreciation | 2022-10-01 → 2023-09-30 | ¥4m |
| IT Sales Outsourcing Businessreportable segment | employees | at 2023-09-30 | 180 pure |
| IT Sales Outsourcing Businessreportable segment | revenue | 2022-10-01 → 2023-09-30 | ¥1.1bn |
| IT Sales Outsourcing Businessreportable segment | revenue external | 2022-10-01 → 2023-09-30 | ¥1.1bn |
| IT Sales Outsourcing Businessreportable segment | segment assets | at 2023-09-30 | ¥141m |
| IT Sales Outsourcing Businessreportable segment | segment profit | 2022-10-01 → 2023-09-30 | ¥263m |
| —segment total | capex | 2022-10-01 → 2023-09-30 | ¥5m |
| —segment total | depreciation | 2022-10-01 → 2023-09-30 | ¥4m |
| —segment total | revenue | 2022-10-01 → 2023-09-30 | ¥1.3bn |
| —segment total | revenue external | 2022-10-01 → 2023-09-30 | ¥1.3bn |
| —segment total | segment assets | at 2023-09-30 | ¥165m |
| —segment total | segment profit | 2022-10-01 → 2023-09-30 | ¥264m |
| Total Of Reportable Segments And Otherssegment total | capex | 2022-10-01 → 2023-09-30 | ¥5m |
| Total Of Reportable Segments And Otherssegment total | depreciation | 2022-10-01 → 2023-09-30 | ¥4m |
| Total Of Reportable Segments And Otherssegment total | revenue | 2022-10-01 → 2023-09-30 | ¥1.3bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2022-10-01 → 2023-09-30 | ¥1.3bn |
| Total Of Reportable Segments And Otherssegment total | segment assets | at 2023-09-30 | ¥165m |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2022-10-01 → 2023-09-30 | ¥251m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue | 2021-10-01 → 2022-09-30 | ¥2m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue external | 2021-10-01 → 2022-09-30 | ¥2m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment profit | 2021-10-01 → 2022-09-30 | −¥9m |
| Reconciling Itemsreconciling | depreciation | 2021-10-01 → 2022-09-30 | ¥462,000 |
| Reconciling Itemsreconciling | segment assets | at 2022-09-30 | ¥678m |
| Reconciling Itemsreconciling | segment profit | 2021-10-01 → 2022-09-30 | −¥149m |
| Health Care Businessreportable segment | capex | 2021-10-01 → 2022-09-30 | ¥6m |
| Health Care Businessreportable segment | depreciation | 2021-10-01 → 2022-09-30 | ¥253,000 |
| Health Care Businessreportable segment | revenue | 2021-10-01 → 2022-09-30 | ¥163m |
| Health Care Businessreportable segment | revenue external | 2021-10-01 → 2022-09-30 | ¥163m |
| Health Care Businessreportable segment | segment assets | at 2022-09-30 | ¥25m |
| Health Care Businessreportable segment | segment profit | 2021-10-01 → 2022-09-30 | −¥3m |
| IT Sales Outsourcing Businessreportable segment | capex | 2021-10-01 → 2022-09-30 | ¥897,000 |
| IT Sales Outsourcing Businessreportable segment | depreciation | 2021-10-01 → 2022-09-30 | ¥2m |
| IT Sales Outsourcing Businessreportable segment | revenue | 2021-10-01 → 2022-09-30 | ¥977m |
| IT Sales Outsourcing Businessreportable segment | revenue external | 2021-10-01 → 2022-09-30 | ¥977m |
| IT Sales Outsourcing Businessreportable segment | segment assets | at 2022-09-30 | ¥127m |
| IT Sales Outsourcing Businessreportable segment | segment profit | 2021-10-01 → 2022-09-30 | ¥210m |
| —segment total | capex | 2021-10-01 → 2022-09-30 | ¥7m |
| —segment total | depreciation | 2021-10-01 → 2022-09-30 | ¥3m |
| —segment total | revenue | 2021-10-01 → 2022-09-30 | ¥1.1bn |
| —segment total | revenue external | 2021-10-01 → 2022-09-30 | ¥1.1bn |
| —segment total | segment assets | at 2022-09-30 | ¥152m |
| —segment total | segment profit | 2021-10-01 → 2022-09-30 | ¥207m |
| Total Of Reportable Segments And Otherssegment total | capex | 2021-10-01 → 2022-09-30 | ¥7m |
| Total Of Reportable Segments And Otherssegment total | depreciation | 2021-10-01 → 2022-09-30 | ¥3m |
| Total Of Reportable Segments And Otherssegment total | revenue | 2021-10-01 → 2022-09-30 | ¥1.1bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2021-10-01 → 2022-09-30 | ¥1.1bn |
| Total Of Reportable Segments And Otherssegment total | segment assets | at 2022-09-30 | ¥152m |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2021-10-01 → 2022-09-30 | ¥198m |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 914
| Item | Context | Value | Unit |
|---|---|---|---|
| Net sales | CurrentYearDuration_NonConsolidatedMember_ReportableSegmentsMember | 1275778000 | JPY |
| Net sales | CurrentYearDuration_NonConsolidatedMember_OperatingSegmentsNotIncludedInReportableSegmentsAndOtherRevenueGeneratingBusinessActivitiesMember | 4171000 | JPY |
| Net sales | CurrentYearDuration_NonConsolidatedMember_TotalOfReportableSegmentsAndOthersMember | 1279949000 | JPY |
| Net sales | CurrentYearDuration_NonConsolidatedMember_ReconcilingItemsMember | － | JPY |
| Net sales | CurrentYearDuration_NonConsolidatedMember | 1279949000 | JPY |
| Operating income | CurrentYearDuration_NonConsolidatedMember_jpcrp030000-asr_E36655-000ITSalesOutsourcingBusinessReportableSegmentMember | 263096000 | JPY |
| Operating income | CurrentYearDuration_NonConsolidatedMember_jpcrp030000-asr_E36655-000HealthCareBusinessReportableSegmentMember | 457000 | JPY |
| Operating income | CurrentYearDuration_NonConsolidatedMember_ReportableSegmentsMember | 263553000 | JPY |
| Operating income | CurrentYearDuration_NonConsolidatedMember_OperatingSegmentsNotIncludedInReportableSegmentsAndOtherRevenueGeneratingBusinessActivitiesMember | -12238000 | JPY |
| Operating income | CurrentYearDuration_NonConsolidatedMember_TotalOfReportableSegmentsAndOthersMember | 251315000 | JPY |
| Operating income | CurrentYearDuration_NonConsolidatedMember_ReconcilingItemsMember | -183995000 | JPY |
| Operating income | CurrentYearDuration_NonConsolidatedMember | 67319000 | JPY |
| Assets | CurrentYearInstant_NonConsolidatedMember_jpcrp030000-asr_E36655-000ITSalesOutsourcingBusinessReportableSegmentMember | 140515000 | JPY |
| Assets | CurrentYearInstant_NonConsolidatedMember_jpcrp030000-asr_E36655-000HealthCareBusinessReportableSegmentMember | 24680000 | JPY |
| Assets | CurrentYearInstant_NonConsolidatedMember_ReportableSegmentsMember | 165196000 | JPY |
| Assets | CurrentYearInstant_NonConsolidatedMember_OperatingSegmentsNotIncludedInReportableSegmentsAndOtherRevenueGeneratingBusinessActivitiesMember | － | JPY |
| Assets | CurrentYearInstant_NonConsolidatedMember_TotalOfReportableSegmentsAndOthersMember | 165196000 | JPY |
| Assets | CurrentYearInstant_NonConsolidatedMember_ReconcilingItemsMember | 749806000 | JPY |
| Assets | CurrentYearInstant_NonConsolidatedMember | 915003000 | JPY |
| Depreciation segment information | CurrentYearDuration_NonConsolidatedMember_jpcrp030000-asr_E36655-000ITSalesOutsourcingBusinessReportableSegmentMember | 3914000 | JPY |
| Depreciation segment information | CurrentYearDuration_NonConsolidatedMember_jpcrp030000-asr_E36655-000HealthCareBusinessReportableSegmentMember | 235000 | JPY |
| Depreciation segment information | CurrentYearDuration_NonConsolidatedMember_ReportableSegmentsMember | 4149000 | JPY |
| Depreciation segment information | CurrentYearDuration_NonConsolidatedMember_OperatingSegmentsNotIncludedInReportableSegmentsAndOtherRevenueGeneratingBusinessActivitiesMember | － | JPY |
| Depreciation segment information | CurrentYearDuration_NonConsolidatedMember_TotalOfReportableSegmentsAndOthersMember | 4149000 | JPY |
| Depreciation segment information | CurrentYearDuration_NonConsolidatedMember_ReconcilingItemsMember | 1029000 | JPY |
| Depreciation segment information | CurrentYearDuration_NonConsolidatedMember | 5179000 | JPY |
| Impairment loss segment information | CurrentYearDuration_NonConsolidatedMember_jpcrp030000-asr_E36655-000ITSalesOutsourcingBusinessReportableSegmentMember | － | JPY |
| Impairment loss segment information | CurrentYearDuration_NonConsolidatedMember_jpcrp030000-asr_E36655-000HealthCareBusinessReportableSegmentMember | 150000 | JPY |
| Impairment loss segment information | CurrentYearDuration_NonConsolidatedMember_ReportableSegmentsMember | 150000 | JPY |
| Impairment loss segment information | CurrentYearDuration_NonConsolidatedMember_OperatingSegmentsNotIncludedInReportableSegmentsAndOtherRevenueGeneratingBusinessActivitiesMember | － | JPY |
| Impairment loss segment information | CurrentYearDuration_NonConsolidatedMember_TotalOfReportableSegmentsAndOthersMember | 150000 | JPY |
| Impairment loss segment information | CurrentYearDuration_NonConsolidatedMember_ReconcilingItemsMember | － | JPY |
| Impairment loss segment information | CurrentYearDuration_NonConsolidatedMember | 150000 | JPY |
| Increase in property plant and equipment and intangible assets | CurrentYearDuration_NonConsolidatedMember_jpcrp030000-asr_E36655-000ITSalesOutsourcingBusinessReportableSegmentMember | 4750000 | JPY |
| Increase in property plant and equipment and intangible assets | CurrentYearDuration_NonConsolidatedMember_jpcrp030000-asr_E36655-000HealthCareBusinessReportableSegmentMember | 189000 | JPY |
| Increase in property plant and equipment and intangible assets | CurrentYearDuration_NonConsolidatedMember_ReportableSegmentsMember | 4940000 | JPY |
| Increase in property plant and equipment and intangible assets | CurrentYearDuration_NonConsolidatedMember_OperatingSegmentsNotIncludedInReportableSegmentsAndOtherRevenueGeneratingBusinessActivitiesMember | － | JPY |
| Increase in property plant and equipment and intangible assets | CurrentYearDuration_NonConsolidatedMember_TotalOfReportableSegmentsAndOthersMember | 4940000 | JPY |
| Increase in property plant and equipment and intangible assets | CurrentYearDuration_NonConsolidatedMember_ReconcilingItemsMember | 25055000 | JPY |
| Increase in property plant and equipment and intangible assets | CurrentYearDuration_NonConsolidatedMember | 29995000 | JPY |
| Document title cover page | FilingDateInstant | Original text (Japanese)有価証券報告書 | |
| Clause of stipulation cover page | FilingDateInstant | Original text (Japanese)金融商品取引法第24条第１項 | |
| Place of filing cover page | FilingDateInstant | Original text (Japanese)近畿財務局長 | |
| Filing date cover page | FilingDateInstant | 2023-12-22 | |
| Fiscal year cover page | FilingDateInstant | Original text (Japanese)第10期(自 2022年10月１日 至 2023年９月30日) | |
| Company name cover page | FilingDateInstant | Original text (Japanese)ＢＣＣ株式会社 | |
| Company name in english cover page | FilingDateInstant | BCC Co.,Ltd. | |
| Title and name of representative cover page | FilingDateInstant | Original text (Japanese)代表取締役社長 伊藤 一彦 | |
| Address of registered headquarter cover page | FilingDateInstant | Text · Plus | |
| Telephone number address of registered headquarter cover page | FilingDateInstant | Original text (Japanese)06-6208-5030 （2023年４月３日より本店移転に伴い電話番号を変更しております。） |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 13 of 13 passed
| balance sheet identity | pass |
| balance sheet identity | pass rounding |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |